Vitamin D: Bolus Is Bogus-A Narrative Review.
Richard B MazessHeike Annette Bischoff-FerrariBess Dawson-HughesPublished in: JBMR plus (2021)
In this review we summarize the impact of bolus versus daily dosing of vitamin D on 25(OH)D and 1,25(OH) 2 D levels, as well as on key countervailing factors that block vitamin D functions at the cellular level. Further, we discuss the role of bolus versus daily dosing of vitamin D for several health outcomes, including respiratory infections and coronavirus disease 2019 (COVID-19), rickets, falls and fractures, any cancer, and cancer-related mortality. This discussion appears timely because bolus doses continue to be tested for various disease outcomes despite a growing amount of evidence suggesting lack of efficacy or even detrimental effects of bolus dosing of vitamin D for outcomes where daily dosing at modest levels was effective in the vitamin D deficient. As a result, these discordant results may bias health recommendations for vitamin D if the recommendations are based on meta-analyses combining both daily and bolus dosing trials. © 2021 The Authors. JBMR Plus published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research.
Keyphrases
- coronavirus disease
- physical activity
- healthcare
- meta analyses
- mental health
- cardiovascular disease
- randomized controlled trial
- type diabetes
- metabolic syndrome
- skeletal muscle
- clinical practice
- risk assessment
- body composition
- bone mineral density
- insulin resistance
- postmenopausal women
- weight loss
- respiratory tract